Back to search results

TELESCOPE: Improving Shared Decision-Making for Lung Cancer Screening

This study, called TELESCOPE, is testing a new approach to help people make informed decisions about lung cancer screening. The TELESCOPE intervention provides coaching and support to help you understand your options, decide if screening is right for you, and connect you with services like smoking cessation if needed. Researchers want to see if this coaching helps people make better decisions about screening, increases their understanding of lung cancer screening benefits and risks, and leads to more people getting screened if they choose to. They also want to see if it helps current smokers get connected to programs to help them quit. You may be able to join if you are 50 to 77 years old, have a history of smoking, and meet certain other criteria. The study aims to enroll 594 participants.

Study design
This is an interventional study comparing the TELESCOPE coaching program to usual care. It plans to enroll 594 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your shared decision-making will be measured at the start of the study, at three months, and at five years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05491213

TELESCOPE- TELEhealth Shared Decision-making COaching

Recruiting
NAAges 18+InterventionalScreening
Rutgers, The State University of New Jersey
~594 participants
Updated 2025-12-09 on ClinicalTrials.gov
What's tested:TELESCOPE, Remote Decision Coaching with Navigation Intervention

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To assess shared decision making
Measured over The change in baseline, three months and five years

Conditions

Lung Neoplasms

Explore related trials

Lung Carcinoma

Where it's being run

2 sites across 2 states
New Jersey1
Texas1

Study leadership

  • Anita Y Kinney, PhD, RN · PRINCIPAL_INVESTIGATOR · Rutgers Cancer Institute

Who to contact

Julie E Chapman-Greene, PhD, MPH
[email protected]
732-865-3375
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be 50 to 77 years of age
Be a current or former smoker having quit within the past 15 years
Have at least a 20 pack-year smoking history
Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)
A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)
Age 18 or older
Fluent in English Online surveys (N=130)
A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
Age 18 or older
Fluent in English

Exclusion

Do not speak English
Have a history lung cancer
Were screened for lung cancer within the past 12 months
Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider
Are unable to provide informed consent Interviews (N=50)
Are unable to provide informed consent Online surveys (N=130)
Are unable to provide informed consent
Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.

What this trial measures

  • To assess shared decision makingThe change in baseline, three months and five years

    Semi-structured interviews (qualitative data)